Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2009
09/10/2009US20090227584 2-aminoquinoline derivatives
09/10/2009US20090227583 2-aminoquinolines
09/10/2009US20090227580 Bicyclic derivatives as CETP inhibitors
09/10/2009US20090227579 Pteridine Derivatives and their Use as Cathespin Inhibitors
09/10/2009US20090227572 Treatment of diabetic wounds and peripheral neuropathies
09/10/2009US20090227571 Androgen Receptor Modulator Compounds and Methods
09/10/2009US20090227570 2-aminoquinolines
09/10/2009US20090227566 Such as N-(4-Chlorophenyl)-2-[4-(N,N-dimethylamino)-2-(piperidin-4-yloxy)-benzoylamino]benzamide; Factor Xa inhibitors
09/10/2009US20090227565 Biphenyl Vasopressin Agonists
09/10/2009US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase
09/10/2009US20090227557 Substituted beta-lactams
09/10/2009US20090227555 Novel Pyridine Compounds
09/10/2009US20090227538 N-(Hetero)Aryl Indole Derivatives as Pesticides
09/10/2009US20090226954 Labeling of target molecules, identification of organelles and other applications, novel compositions, methods and kits
09/10/2009US20090226411 Chemical derivatives and their application as antitelomerase agents
09/09/2009EP2098508A1 Cyclic derivatives as modulators of chemokine receptor activity
09/09/2009EP2097405A2 Anti-viral compounds
09/09/2009EP2097404A1 Substituted dipyridyl-dihydropyrazolones and use thereof
09/09/2009EP2097403A2 New polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate
09/09/2009EP2097402A1 Macrocyclic inhibitors of hepatitis c virus
09/09/2009EP2097401A1 Processes for the preparation of (3r, 4r) -n- (4 -chlorophenyl) -1- (2, 2-difluoroethyl) -n' - [2-fluoro-4- (2-oxo-1 (2h) -pyridinyl) phenyl]-3, 4-pyrrolidinedicarboxamide
09/09/2009EP2097400A2 Fused substituted aminopyrrolidine derivative
09/09/2009EP2097386A2 Substituted dihydroimidazoles and their use in the treatment of tumors
09/09/2009EP2097385A1 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands
09/09/2009EP2097384A1 Indozalyl sulphonamide derivatives useful as glucocorticoid modulators
09/09/2009EP2097382A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of no synthase
09/09/2009EP2097377A1 Renin inhibitors
09/09/2009EP2097374A2 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of v2 vasopressin receptors
09/09/2009EP1732917B8 Selected cgrp antagonists, methods for the production thereof and their use as medicaments
09/09/2009EP1638963B1 N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors
09/09/2009EP1422227B1 Process for producing pyridine compound
09/09/2009EP1397355B1 Pyridyl cyanoguanidine compounds
09/09/2009CN101528736A Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligands
09/09/2009CN101528735A New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone HSP90
09/09/2009CN101528734A 3 -amino- pyridine derivatives for the treatment of metabolic disorders
09/09/2009CN101528733A 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin-2-one as CBL' receptor modulators
09/09/2009CN101528732A 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin-2-one as CB1 receptor modulators
09/09/2009CN101528731A Novel aminopyridine derivative having Aurora A-selective inhibitory activity
09/09/2009CN101528730A Substituted imidazoles as bombesin receptor subtype-3 modulators
09/09/2009CN101528729A Pyrimidone compounds as GSK-3 inhibitors
09/09/2009CN101528728A 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
09/09/2009CN101525331A Phosphopyridoxal intermediates, preparation method of same, application of same, and method for preparing phosphopyridoxal therefrom
09/09/2009CN101525330A Phosphopyridoxal intermediates, preparation method of same, application of same, and method for preparing phosphopyridoxal therefrom
09/09/2009CN101524356A Use of dopamine D3 receptor ligands for production of drugs for treating renal function disorders
09/09/2009CN100537564C Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5
09/09/2009CN100537563C Process for preparing N-phenyl-2-pyrimidyl amine derivative
09/09/2009CN100537562C Pyridyl-triazine derivatives as microbicidal active substances
09/09/2009CN100537561C Method for preparing 3-halo-4,5-dihydro-1H-pyrazoles
09/09/2009CN100537546C Novel alkansulfonamides as endothelin antagonists
09/09/2009CN100537545C Pesticides
09/09/2009CN100537542C Farnesyl protein transferase inhibitors as antitumor agents
09/09/2009CN100537534C Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
09/09/2009CN100537523C Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease
09/08/2009US7585978 Processes of manufacturing substituted-1,4-dihydropyridines, improved aqueous solutions thereof, and processes of manufacturing the solutions
09/08/2009US7585976 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting
09/08/2009US7585975 A group is bonded to at least one of the carbons at the 5, 6, 7 or 8 position of the bicyclic ring, and the ring is substituted by up to three independent R3 groups. The invention also includes methods of using these compounds as type I receptor tyrosine kinase inhibitors and hyperproliferation diseases
09/08/2009US7585974 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, their preparation and their therapeutic application
09/08/2009US7585885 Beta -secretase (BACE); Alzheimer's disease; 2-(R)-[2-(S)-Amino-3-(3,5-difluorophenyl)-1-(S)-hydroxypropyl]-pyrrolidine-1-carboxylic acid tert-butyl ester
09/08/2009US7585881 2-[5-(3-Methoxy-phenyl)-[1,2,4]oxadiazol-3-ylmethylsulfanyl]-1H-benzoimidazole, for example; useful for the inhibition of transient lower esophageal sphincter relaxations and thus for treatment of gastro-esophageal reflux disorder
09/08/2009US7585879 Biphenyl compounds useful as muscarinic receptor antagonists
09/08/2009US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder
09/08/2009US7585869 novel bicyclic derivatives that are useful in the treatment of abnormal cell growth, such as cancer; tyrosine kinase inhibitors
09/08/2009US7585866 Protein tyrosine kinase inhibitors
09/08/2009US7585853 Compounds having selective inhibiting effect at GSK3
09/08/2009CA2478066C Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
09/08/2009CA2458929C Process for preparing aripiprazole
09/08/2009CA2442210C Aryl oxime-piperazines useful as ccr5 antagonists
09/08/2009CA2387351C Indole derivatives as tyrosine kinase inhibitors
09/08/2009CA2360360C Piperidyl benzamide compounds, composition containing same and their use thereof
09/08/2009CA2342739C Azetidine derivatives, preparation and medicines containing them
09/08/2009CA2316388C Tetrahydrobenzindole derivative
09/08/2009CA2293714C Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase
09/08/2009CA2287558C Heterocyclic derivatives and their use as antithrombotic agents
09/08/2009CA2213466C Inhibitors of microsomal triglyceride transfer protein and method
09/03/2009WO2009108766A1 Gamma secretase modulators for the treatment of alzheimer ' s disease
09/03/2009WO2009108117A1 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177
09/03/2009WO2009107391A1 Compound having 6-membered aromatic ring
09/03/2009WO2009106982A1 Indazole derivatives
09/03/2009WO2009106980A2 Indazole derivatives
09/03/2009WO2009106753A1 Novel derivatives of 1h-indol-1-yl urea, method for preparing same and pharmaceutical compositions containing same
09/03/2009WO2009106745A2 Method for enantio-selective preparation of sulphoxides
09/03/2009WO2009106586A1 Quinolines as inhibitors of farnesyl pyrophosphate synthase
09/03/2009WO2009106565A1 Agonists of gpr119
09/03/2009WO2009106561A1 Pyrazine compounds for treating gpr119 related disorders
09/03/2009WO2009106534A1 Novel heterocyclic carboxamides as m1 agonists
09/03/2009WO2009106209A1 Carboxamide-heteroaryl derivatives for the treatment of diabetes
09/03/2009WO2009105906A1 Flavor molecules
09/03/2009WO2009105825A1 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists
09/03/2009WO2009105824A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
09/03/2009WO2009105823A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
09/03/2009WO2009080799A3 Carbazole-based hole transport and /or electron blocking materials and /or host polymer materials
09/03/2009WO2009077052A3 Process for preparing tetrahydroquinoline derivatives
09/03/2009WO2009075516A3 Process for preparing pantoprazole sodium sesquihydrate
09/03/2009WO2009058937A3 Heteroaryl ethers and processes for their preparation
09/03/2009WO2009055467A3 Compounds that inhibit protease cathepsin s and hcv replication
09/03/2009WO2008131860A3 Pyridonecarboxamides crop protection agents containing the same method for production and use thereof
09/03/2009US20090221831 Method for Producing N,N-Bis(Pyridin-2Ylmethyl)-1,1-Bis(Pyridin-2-Yl)-1-Aminoalkane Compounds and Metal Complex Salts Containing These Compounds
09/03/2009US20090221828 Process for Preparing 1-Halo-2,7-Naphthyridinyl Derivatives
09/03/2009US20090221820 Ligands for Transition-Metal-Catalyzed Cross-Couplings, and Methods of Use Thereof
09/03/2009US20090221817 Triethylamine was added dropwise to a solution of 2-methylpropane-2-sulfinyl chloride and methyl trans-4-amino-1-cyclohexane carboxylate p-toluenesulfonate in tetrahydrofuran solvent to obtain Methyl trans-4-(2-methylpropane-2-sulfonylamino)cyclohexanecarboxylate; hydrolysis; oxidation; intermediates